Schulz SC - Search Results

1

Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.

Kahn RS, Schulz SC, Palazov VD, Reyes EB, Brecher M, Svensson O, Andersson HM, Meulien D; Study 132 Investigators. Kahn RS, et al. Among authors: schulz sc. J Clin Psychiatry. 2007 Jun;68(6):832-42. doi: 10.4088/jcp.v68n0603. J Clin Psychiatry. 2007. PMID: 17592906 Clinical Trial.

2

The efficacy of quetiapine vs haloperidol and placebo: a meta-analytic study of efficacy.

Schulz SC, Thomson R, Brecher M. Schulz SC, et al. Schizophr Res. 2003 Jul 1;62(1-2):1-12. doi: 10.1016/s0920-9964(02)00522-4. Schizophr Res. 2003. PMID: 12765737

3

Comparison of low and moderate dosages of extended-release quetiapine in borderline personality disorder: a randomized, double-blind, placebo-controlled trial.

Black DW, Zanarini MC, Romine A, Shaw M, Allen J, Schulz SC. Black DW, et al. Among authors: schulz sc. Am J Psychiatry. 2014 Nov 1;171(11):1174-82. doi: 10.1176/appi.ajp.2014.13101348. Am J Psychiatry. 2014. PMID: 24968985 Clinical Trial.

4

Clinical use of quetiapine in disease states other than schizophrenia.

Adityanjee, Schulz SC. Adityanjee, et al. Among authors: schulz sc. J Clin Psychiatry. 2002;63 Suppl 13:32-8. J Clin Psychiatry. 2002. PMID: 12562145 Review.

5

Quetiapine in patients with borderline personality disorder: an open-label trial.

Adityanjee, Romine A, Brown E, Thuras P, Lee S, Schulz SC. Adityanjee, et al. Among authors: schulz sc. Ann Clin Psychiatry. 2008 Oct-Dec;20(4):219-26. doi: 10.1080/10401230802467545. Ann Clin Psychiatry. 2008. PMID: 19034754 Clinical Trial.

6

Efficacy of extended-release divalproex combined with "condensed" dialectical behavior therapy for individuals with borderline personality disorder.

Moen R, Freitag M, Miller M, Lee S, Romine A, Song S, Adityanjee A, Schulz SC. Moen R, et al. Among authors: schulz sc. Ann Clin Psychiatry. 2012 Nov;24(4):255-60. Ann Clin Psychiatry. 2012. PMID: 23145381 Clinical Trial.

7

A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study.

Zanarini MC, Schulz SC, Detke HC, Tanaka Y, Zhao F, Lin D, Deberdt W, Kryzhanovskaya L, Corya S. Zanarini MC, et al. Among authors: schulz sc. J Clin Psychiatry. 2011 Oct;72(10):1353-62. doi: 10.4088/JCP.08m04138yel. J Clin Psychiatry. 2011. PMID: 21535995 Clinical Trial.

8

Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study.

Schulz SC, Zanarini MC, Bateman A, Bohus M, Detke HC, Trzaskoma Q, Tanaka Y, Lin D, Deberdt W, Corya S. Schulz SC, et al. Br J Psychiatry. 2008 Dec;193(6):485-92. doi: 10.1192/bjp.bp.107.037903. Br J Psychiatry. 2008. PMID: 19043153 Clinical Trial.

9

Quetiapine's effect on the SCL-90-R domains in patients with borderline personality disorder.

Lee SS, Allen J, Black DW, Zanarini MC, Schulz SC. Lee SS, et al. Among authors: schulz sc. Ann Clin Psychiatry. 2016 Feb;28(1):4-10. Ann Clin Psychiatry. 2016. PMID: 26855980 Clinical Trial.

10

Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.

Kryzhanovskaya L, Schulz SC, McDougle C, Frazier J, Dittmann R, Robertson-Plouch C, Bauer T, Xu W, Wang W, Carlson J, Tohen M. Kryzhanovskaya L, et al. Among authors: schulz sc. J Am Acad Child Adolesc Psychiatry. 2009 Jan;48(1):60-70. doi: 10.1097/CHI.0b013e3181900404. J Am Acad Child Adolesc Psychiatry. 2009. PMID: 19057413 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters